Dr. Rosalyn Juergens on Managing Acquired Resistance to Targeted Therapies for Advanced NSCLC
13 mar 2013 ·
1 min. 58 sec.
![Dr. Rosalyn Juergens on Managing Acquired Resistance to Targeted Therapies for Advanced NSCLC](https://d3wo5wojvuv7l.cloudfront.net/t_square_limited_480/images.spreaker.com/original/09ad357d92acf8aee6fade5106b09054.jpg)
Scarica e ascolta ovunque
Scarica i tuoi episodi preferiti e goditi l'ascolto, ovunque tu sia! Iscriviti o accedi ora per ascoltare offline.
Descrizione
Dr. Rosalyn Juergens, McMaster University, explains her approach to management of acquired resistance to targeted therapies in patients with a "driver mutation" and respond well initially to treatment.
Informazioni
Autore | cancerGRACE |
Sito | - |
Tag |
Copyright 2024 - Spreaker Inc. an iHeartMedia Company